Incuron, LLC is a joint venture between Russian Closed Mutual Venture Fund "Bioprocess Capital Ventures," and Cleveland BioLabs, Inc. Bioprocess Capital Ventures is a Russian Federation Venture Capital Fund managed by "Bioprocess Capital Partners, LLC," which was founded by several Russian investors including "Russian Venture Company," JSC and state corporation VneshEconomBank (VEB). The Fund focuses on investments in innovative projects in the pharmaceutical, biotechnology, and fine chemistry sectors of the economy. Incuron's strategy includes preclinical and clinical development of breakthrough biotechnologies discovered by CBLI with the subsequent introduction of brand new anticancer drugs with novel mechanism of action ("Curaxins") to both Russian and American markets.
| Website | http://www.incuron.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 2009 |
| Address | 73 High St, Buffalo, New York 14203, US |
| Phone | +7 495 974-74-01 |
| Fax | (716) 588-0007 |
| Industry | Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Pharmaceutical, Therapeutics |
| Competitors | Merck & Co., Inc., Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Gilead Sciences, Lilly India +44 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Incuron LLC employee's phone or email?
Incuron LLC Questions
The Incuron LLC annual revenue was $5 million in 2026.
Incuron LLC is based in Buffalo, New York.
The NAICS codes for Incuron LLC are [5417, 541714, 54171, 541, 54].
The SIC codes for Incuron LLC are [87, 873].
